Molecular Templates to Participate in Upcoming Virtual Investor Conferences
AUSTIN, Texas, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of the company’s proprietary engineered toxin bodies (ETBs), which are differentiated, targeted, biologic therapeutics for cancer and other serious diseases, today announced that it will deliver presentations and participate in 1on1 meetings at the Stifel 2020 Virtual Healthcare Conference and the 3rd Annual Evercore ISI HealthCONx Conference. In addition, management will be available for virtual 1on1 meetings at the Jefferies Virtual London Healthcare Conference.
About Molecular Templates
Source: Molecular Templates, Inc.
Keynote Roundtable Discussion